# Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?

> **NCT02680314** · PHASE2 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 243 (actual)

## Conditions studied

- Labor; Forced or Induced, Affecting Fetus or Newborn

## Interventions

- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT02680314
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-05-17
- **Final completion:** 2021-06-16
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680314, "Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02680314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*